Mirabellsoft participates in CES 2025: Responding to global demand for chronic disease management and telemedicine solutions with ‘MD PACS’ and ‘CareForMe’ apps
Mirabellsoft (CEO Park Kiho) announced that it will exhibit at CES 2025, which will be held from January 7th (Tuesday) to January 10th (Friday) in Las Vegas, USA, under the “K-Startup Pavilion.”
<div
Based on the healthcare experience of its physician CEO, Mirabellsoft developed the “Health Chemistry Platform,” an integrated healthcare platform designed for primary care institutions to share information and connect consultations. Its core products include “MD PACS,” a new system for integrated health information management and sharing based on PACS, and “CareforMe,” an app that enables health management with a doctor.
The company is expanding its business scope with patient-tailored “healthcare institution management services,” a telemedicine and medical big data platform specialized in chronic diseases, and developing a CDSS (Clinical Decision Support System) to diagnose conditions like cardiac arrhythmia.
Mirabellsoft is leading healthcare IT innovation with AI-based diagnostic technology and telemedicine solutions. The company emphasized that its CareForMe app and MD PACS, used by 700 hospitals, 1,000 doctors, and 26,000 patients, have demonstrated excellent performance in managing chronic diseases. Strengthening partnerships to enter Southeast Asia, Central Asia, and the Middle East, Mirabellsoft aims to expand its global market reach through CES 2025. By combining AI technology and medical data analysis, it seeks to set new standards for healthcare services while pursuing sustainable development and enhanced competitiveness.
Through its participation at CES 2025, Mirabellsoft aims to strengthen its position in the global healthcare IT market and showcase its innovative medical solutions internationally.
Mirabellsoft has prioritized entry into Southeast Asia, Central Asia, and the Middle East. These regions are experiencing rapid medical system development, with a particularly high demand for chronic disease management and telemedicine solutions. The CareForMe app and MD PACS offer innovative solutions to improve medical accessibility and provide efficient treatment in these areas. Mirabellsoft stated, “We expect that our technology will revolutionize healthcare services and contribute to improving medical quality in these regions.”
The company added, “In Southeast Asia, we plan to expand our business in collaboration with current partners, such as Omi Group. We aim to utilize networks in countries like Kyrgyzstan and Kazakhstan for Central Asia. We will expand operations with existing partners for the Middle East and target the U.S. and European markets for broader global expansion.”
